Study of LEE011plus Cetuximab in Patients With a Cancer of the Head and Neck
Status:
Terminated
Trial end date:
2018-09-01
Target enrollment:
Participant gender:
Summary
In this trial, the investigators would like to investigate the activity of LEE011 associated
with cetuximab (standard of care for the SCCHN patients at this stade of the disease).
Phase:
Phase 1
Details
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain